India drags its feet on a marketing code for drug companies

Online and offline media have extensively covered the $3bn fine levied by the US government on UK's GlaxoSmithKline for illegal and unethical marketing of a clutch of brands. See here. Back in India, drug companies are apparently above reproach. It's over a year since India's department of pharmaceuticals (DoP) published a draft code of marketing … Continue reading India drags its feet on a marketing code for drug companies

Advertisement